Cytokine production and signaling pathways

Cytokine production and signaling pathways represent a broad category of biological processes involving the synthesis, secretion, and cellular response to cytokines, which are essential chemical messengers of the immune system. These pathways, including the JAK-STAT, NF-kappaB, and MAPK cascades, coordinate the body's response to infection, tissue injury, and inflammation by regulating cell growth, differentiation, and activation (Source: StatPearls). In many pathological conditions, such as rheumatoid arthritis, psoriasis, and cytokine storm syndromes, these pathways become overactive or dysregulated, leading to chronic inflammation and tissue damage (Source: PubMed). Pharmacological modulation of these pathways is a cornerstone of modern immunology, utilizing biologics like monoclonal antibodies to neutralize cytokines or small molecule inhibitors to block intracellular signaling components (Source: NIH). While highly effective, targeting these pathways carries significant safety concerns, primarily related to systemic immunosuppression and an increased susceptibility to opportunistic infections. Consequently, these pathways are not considered a single therapeutic target but rather a complex network of individual molecular targets that require specific intervention strategies (Source: PubMed). Monitoring biomarkers like C-reactive protein and specific cytokine levels is essential for assessing the efficacy and safety of therapies targeting these pathways.

Other names

Cytokine signalingCytokine-mediated signaling pathwayCytokine production

Mechanisms include the neutralization of circulating cytokines, competitive antagonism of cytokine receptors, and the inhibition of intracellular signaling transducers such as Janus kinases (JAKs) to prevent gene transcription.